###begin article-title 0
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
Variation in CHI3LI in Relation to Type 2 Diabetes and Related Quantitative Traits
###end article-title 0
###begin p 1
Conceived and designed the experiments: CNR TJ KBJ TH OBP HV. Performed the experiments: CNR TJ KBJ TH OBP HV. Analyzed the data: CNR JH. Contributed reagents/materials/analysis tools: CNR JH TH HV. Wrote the paper: CNR. Critical revision of the manuscript: JH TJ KBJ TH OBP HV.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 333 339 333 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 619 625 619 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 771 777 771 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
CHI3LI encoding the inflammatory glycoprotein YKL-40 is located on chromosome 1q32.1. YKL-40 is involved in inflammatory processes and patients with Type 2 Diabetes (T2D) have elevated circulating YKL-40 levels which correlate with their level of insulin resistance. Interestingly, it has been reported that rs10399931 (-329 G/A) of CHI3LI contributes to the inter-individual plasma YKL-40 levels in patients with sarcoidosis, and that rs4950928 (-131 C/G) is a susceptibility polymorphism for asthma and a decline in lung function. We hypothesized that single nucleotide polymorphisms (SNPs) or haplotypes thereof the CHI3LI locus might influence risk of T2D. The aim of the present study was to investigate the putative association between SNPs and haplotype blocks of CHI3LI and T2D and T2D related quantitative traits.
###end p 3
###begin title 4
Methods/Principal Findings
###end title 4
###begin p 5
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 198 206 <span type="species:ncbi:9606">patients</span>
Eleven SNPs of CHI3LI were genotyped in 6514 individuals from the Inter99 cohort and 2924 individuals from the outpatient clinic at Steno Diabetes Center. In cas-control studies a total of 2345 T2D patients and 5302 individuals with a normal glucose tolerance test were examined.
###end p 5
###begin p 6
###xml 323 329 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
We found no association between rs10399931 (OR, 0.98 (CI, 0.88-1.10), p = 0.76), rs4950928 (0.98 (0.87-1.10), p = 0.68) or any of the other SNPs with T2D. Similarly, we found no significant association between any of the 11 tgSNPs and T2D related quantitative traits, all p>0.14. None of the identified haplotype blocks of CHI3LI showed any association with T2D, all p>0.16.
###end p 6
###begin title 7
Conclusions/Significance
###end title 7
###begin p 8
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 262 268 262 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
None of the examined SNPs or haplotype blocks of CHI3LI showed any association with T2D or T2D related quantitative traits. Estimates of insulin resistance and dysregulated glucose homeostasis in T2D do not seem to be accounted for by the examined variations of CHI3LI.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 531 534 531 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-McCarthy1">[1]</xref>
###xml 535 538 535 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-McCarthy3">[3]</xref>
###xml 768 771 768 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-McCarthy1">[1]</xref>
###xml 943 946 943 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Langefeld1">[4]</xref>
###xml 597 602 <span type="species:ncbi:9606">human</span>
The primary molecular defects in Type 2 diabetes (T2D) remain largely unknown, but it is widely recognized that both genetic and environmental risk factors have interacting roles in the pathogenesis and the progression of the disease. However, recent discoveries have led to a progress in the understanding of the molecular genetic background of T2D brought forward by genome-wide association (GWA) studies which have dramatically increased the number of validated type 2 diabetes loci with modest impact on relative diabetes risk [1]-[3]. Several loci of interest may be located in the region of human chromosone 1q21-24 which shows replicated linkage to T2D in at least eight populations including North European Caucasian families, Pima Indians and Old Order Amish [1]. Furthermore, linkage analysis has also provided evidence for linkage of the metabolic syndrome (central obesity, dyslipidemia, hyperglycemia and hypertension) to 1q23-31 [4]. These regions as well as other closely related regions of chromosome 1 are under intense search for identification of T2D susceptibility genes.
###end p 10
###begin p 11
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 312 315 312 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke1">[5]</xref>
###xml 395 398 395 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke2">[6]</xref>
###xml 400 403 400 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke3">[7]</xref>
###xml 529 532 529 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke2">[6]</xref>
###xml 656 659 656 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke4">[8]</xref>
###xml 342 350 <span type="species:ncbi:9606">patients</span>
###xml 539 547 <span type="species:ncbi:9606">patients</span>
Chitinase 3-like 1 (CHI3LI) encoding the inflammatory glycoprotein YKL-40 is located in a phylogenetically highly conserved area on chromosome 1q32.1. YKL-40 is involved in inflammatory processes and extracellular matrix remodelling including angiogenesis and functions as a growth factor for several cell types [5]. Studies have shown, that patients with T2D have elevated plasma YKL-40 levels [6], [7] which correlate with insulin resistance and with their diabetic lipid profile, but not with estimates of glycemic regulation [6]. Also patients with type 1 diabetes (T1D) have elevated YKL-40 levels which increase with increasing levels of albuminuria [8].
###end p 11
###begin p 12
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Kruit1">[9]</xref>
###xml 170 176 170 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 402 406 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Dixon1">[10]</xref>
###xml 504 508 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Ober1">[11]</xref>
###xml 516 522 514 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
###xml 324 342 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 381 389 <span type="species:ncbi:9606">children</span>
The CHI3LI promotor variant -329 G/A (rs10399931) associates with the inter-individual plasma YKL-40 levels in patients with sarcoidosis [9]. Furthermore, the functional CHI3LI promotor SNP -131C-->G (rs4950928) increases the mRNA transcript levels coding for the YKL-40 protein in a genome wide study of gene expression in Epstein-Barr virus-transformed lymphoblastoid cells from children with asthma [10] and is shown to be predictive of asthma, bronchial hyperresponsiveness and reduced lung function [11]. Since CHI3LI is a susceptibility gene for asthma with elevated circulating YKL-40 levels as a biomarker, it is possible that one of these single nucleotide polymorphisms (SNPs) or another gene variation with which they could be in tight linkage disequilibrium with may be functional in relation to T2D.
###end p 12
###begin p 13
###xml 145 151 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
Applying a HapMap-based tgSNP approach the objective of the present study was to investigate the putative association of common variation in the CHI3LI locus with T2D, obesity and several T2D associated quantitative traits.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Ethics Statement
###end title 15
###begin p 16
###xml 47 59 <span type="species:ncbi:9606">participants</span>
Informed written consent was obtained from all participants before participation. The study was approved by the Ethical Committees of Copenhagen and Aarhus and was in accordance with the principle of the Helsinki Declaration II.
###end p 16
###begin title 17
Study population
###end title 17
###begin p 18
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
A total of 11 tgSNPs (including the rs10399931 and rs4950928) covering all haplotype blocks in CHI3LI locus was genotyped. Genotyping was performed in 9438 individuals including Inter99, a population-based sample of unrelated, middle-aged Danish individuals living in the greater Copenhagen area, and 2924 individuals recruited from the outpatient clinic at Steno Diabetes Center.
###end p 18
###begin p 19
###xml 69 73 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Jorgensen1">[12]</xref>
###xml 350 354 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Alberti1">[13]</xref>
###xml 90 102 <span type="species:ncbi:9606">participants</span>
###xml 659 671 <span type="species:ncbi:9606">participants</span>
###xml 839 851 <span type="species:ncbi:9606">participants</span>
The Inter99 study population has been described in detail previously [12]. In brief, both participants from the Inter99 cohort and individuals recruited from the outpatient clinic were characterized by an oral glucose tolerance test (OGTT). Impaired glucose homeostasis (IFG, IGT and diabetes) was defined according to WHO criteria after a 75 g OGTT [13] giving a classification of normal glucose tolerance (NGT; n = 5302), impaired fasting glycemia (IFG; n = 540), impaired glucose tolerance (IGT; n = 830) or screen-detected untreated T2D (SDU DM; n = 294). Missing data was seen in 421 individuals (4.5%) and a total of 2091 individuals had known T2D. The participants were investigated for an association between genotype and quantitative metabolic traits; individuals with known type 2 diabetes were excluded from these analyses. All participants were of Danish nationality.
###end p 19
###begin title 20
Biochemical and anthropometric measurements
###end title 20
###begin p 21
###xml 141 142 141 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Height and body weight were measured in light indoor clothes and without shoes, and BMI was calculated as weight (kg) divided by (height (m))2. Waist circumference was measured in the standing position midway between the iliac crest and the lower costal margin and hip circumference at its maximum.
###end p 21
###begin p 22
###xml 231 233 231 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1C</sub>
###xml 43 55 <span type="species:ncbi:9606">participants</span>
In both Inter99- and Steno Diabetes Center participants, blood samples were drawn in the fasting state after a 12-h overnight fast. Plasma glucose was analysed by a glucose oxidase method (Granutest, Merck, Darmstadt, Germany). HbA1C was measured by ion-exchange high performance liquid chromatography (normal reference range: 4.1-6.4%) and serum insulin (excluding des(31, 32) and intact proinsulin) was measured using the AutoDELFIA insulin kit (Perkin-Elmer/Wallac, Turku, Finland). Serum C-peptide concentrations were measured by a time-resolved fluoroimmunoassay (AutoDELFIA C-peptide kit; Perkin-Elmer/Wallac, Turku, Finland).
###end p 22
###begin p 23
Serum triglyceride and total and HDL-cholesterol were analysed using enzymatic colorimetric methods (GPO-PAP and CHOD-PAP, Roche Molecular Biochemicals, Mannheim, Germany). HOMA-IR was calculated as fasting plasma glucose [mmol/l] multiplied by fasting serum insulin [pmol/l] and divided by 22.5. Insulinogenic index at 30 min was calculated as fasting serum insulin subtracted from plasma insulin at 30 min [pmol/l] divided by plasma glucose at 30 min [mmol/l].
###end p 23
###begin title 24
Genotyping
###end title 24
###begin p 25
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-deBakker1">[14]</xref>
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 382 390 382 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005469-g001">Figure 1</xref>
###xml 331 339 <span type="species:ncbi:9606">patients</span>
SNPs in a region 22 kb upstream and 10 kb downstream of CHI3LI were chosen from the HapMap project (). Haplotype tgSNPs were selected from the HapMap data using TAGGER [14]. TAGGER was used with a 5% MAF cut off, agressive tagging (r2>0.8). Two haplotype blocks with 2 and 5 SNPs, respectively, and with similar structures in both patients with T2D and in controls were identified (Figure 1). The other tgSNPs were not included in the haplotype block analyses since they were not part of any block. Genotyping was performed using TaqMan allelic discrimination (Kbioscience, Herts, UK) with a success rate >97.0%. Discordance was 0% as judged from re-genotyping of 965 random duplicate samples. Genotype distribution obeyed Hardy Weinberg Equilibrium (HWE), all p>0.25.
###end p 25
###begin title 26
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3L1</italic>
Linkage disequilibrium (LD) pattern of the investigated variations of CHI3L1.
###end title 26
###begin title 27
Statistical analyses
###end title 27
###begin p 28
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Purcell1">[15]</xref>
Logistic regression analyses were used to analyse differences in allele and genotype frequencies between case and control subjects; analyses were adjusted for age, sex and BMI where appropriate. The statistical analyses were performed using RGui version 2.5.0 (available at ). The haplotype block analyses were analysed for an association with T2D after adjustment for age, sex and BMI. Haplotype analyses were performed using PLINK [15]. P-values are not adjusted for multiple testing.
###end p 28
###begin title 29
Results
###end title 29
###begin p 30
###xml 120 127 120 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005469-t001">Table 1</xref>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
Clinical characteristics for the Inter99 cohort and the individuals recruited at Steno Diabetes Center are presented in Table 1. A total of 2345 T2D patients and 5302 individuals with a normal glucose tolerance test were identified.
###end p 30
###begin title 31
Clinical data for study sample.
###end title 31
###begin p 32
###xml 65 68 <span type="species:ncbi:9606">men</span>
###xml 69 74 <span type="species:ncbi:9606">women</span>
Data is mean+/-S.D. SDC, Steno Diabetes Center; N (m/w), number (men/women); NGT, normal glucose tolerance; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; SDU DM, screen detected untreated diabetes mellitus; T2D, Type 2 diabetes; BMI, Body Mass Index; HbA1c, hemoglobin A1c.
###end p 32
###begin p 33
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005469-t002">Table 2</xref>
###xml 395 403 395 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005469.s001">Table S1</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005469.s002">S2</xref>
Overall we found no association of rs10399931, rs4950928 or any of the other tgSNPs of CHI3LI with T2D after adjustment for age, sex, BMI and glucose tolerance, all p>0.25 (Table 2). In similar analyses, none of the tgSNPs were associated with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), although a borderline protective association with IGT was detected for rs12123883 (Table S1 and S2).
###end p 33
###begin title 34
###xml 133 139 133 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
###xml 88 100 <span type="species:ncbi:9606">participants</span>
Case control association studies of 2345 T2D patients and 5302 glucose tolerant control participants in relation to the 11 tgSNPs of CHI3LI.
###end title 34
###begin p 35
T2D, type 2 diabetes; SNP, single nucleotide polymorphism; MAF, minor allele frequency; NGT, normal glucose tolerance; OR (CI), odds ratio (confidence interval).
###end p 35
###begin p 36
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005469-t003">Table 3</xref>
###xml 12 13 12 13 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005469-t004">4</xref>
Table 3 and 4 show the multiadjusted association of rs10399931 and rs4950928 with BMI and other T2D related quantitative traits among NGT, IFG, IGT and screen-detected untreated T2D in Inter99 and Steno Diabetes Center collected individuals. We found a significant association between rs10399931 and the serum C-peptide concentration after 2 hours, p = 0.03, but in all we found no significant association between rs10399931 or rs4950928 and any of the T2D quantitative traits. Similarly, none of the other SNPs showed any associations (data not shown).
###end p 36
###begin title 37
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
Association of rs10399931 of CHI3LI and T2D related quantitative traits among NGT, IFG, IGT and screen-detected untreated T2D in Inter99 and Steno Diabetes Center collected individuals.
###end title 37
###begin p 38
Data presented as mean (SD). Analyses adjusted for age, gender, BMI, glucose tolerance (NGT, IFG, IGT and screen-detected untreated T2D).
###end p 38
###begin p 39
T2D, type 2 diabetes; NGT, normal glucose tolerance; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; add, additive; dom, dominant; res, recessive; bmi, body mass index; whratio, waist-to-hip ratio; hdl, high density lipoprotein; bp, blood pressure; HOMA-IR, insulin resistance according to HOMA model.
###end p 39
###begin title 40
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
Association of rs49509028 of CHI3LI and T2D related quantitative traits among NGT, IFG, IGT and screen-detected untreated T2D in Inter99 and Steno Diabetes Center collected individuals.
###end title 40
###begin p 41
Data presented as mean (SD). Analyses adjusted for age, gender, BMI, glucose tolerance (NGT, IFG, IGT and screen-detected untreated T2D).
###end p 41
###begin p 42
T2D, type 2 diabetes; NGT, normal glucose tolerance; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; add, additive; dom, dominant; res, recessive; bmi, body mass index; whratio, waist-to-hip ratio; hdl, high density lipoprotein; bp, blood pressure; HOMA-IR, insulin resistance according to HOMA model.
###end p 42
###begin p 43
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 85 92 85 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005469-t005">Table 5</xref>
The two identified haplotype blocks of CHI3LI did not show any association with T2D (Table 5).
###end p 43
###begin title 44
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
CHI3LI haplotype association studies in relation to T2D.
###end title 44
###begin p 45
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
Data show the association with T2D for the 2 haplotype blocks of 2 respectively 5 genotyped SNPs in CHI3LI. Haplotype tgSNPs were selected from the HapMap data using TAGGER.
###end p 45
###begin p 46
T2D, type 2 diabetes; SNP, single nucleotide polymorphism.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 266 269 266 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke2">[6]</xref>
###xml 271 274 271 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke3">[7]</xref>
###xml 365 368 365 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke4">[8]</xref>
###xml 453 459 453 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 639 642 639 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Kruit1">[9]</xref>
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Ober1">[11]</xref>
###xml 687 693 687 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 248 256 <span type="species:ncbi:9606">patients</span>
###xml 284 292 <span type="species:ncbi:9606">patients</span>
###xml 613 621 <span type="species:ncbi:9606">patients</span>
This is a large-scale and to our knowledge the first study of variation in CHI3LI in relation to T2D and pre-diabetic quantitative traits. CHI3LI encodes the inflammatory protein YKL-40 which previously has been found to be elevated in plasma from patients with T2D [6], [7] and from patients with T1D where it also correlates with increasing levels of albuminuria [8]. In our study, we have exmained 11 tgSNPs covering the common variation (MAF>5%) in CHI3LI including the SNPs rs10399931 and rs4950928 which previously have been found to contribute to interindividual variations in circulating YKL-40 levels in patients with sarcoidosis [9] and asthma [11], respectively. Furthermore, CHI3LI has been found to be a susceptibility gene for asthma, since rs4950928 is predictive of asthma, bronchial hyperresponsiveness and reduced lung function.
###end p 48
###begin p 49
###xml 134 140 134 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
A total of 9438 individuals have been examined, but no significant association of rs10399931, rs4950928 or any of the other tgSNPs of CHI3LI were found with T2D or any of the intermediate T2D related quantitative traits. A borderline protective association with IGT was detected for rs12123883, but rs12123883 is a rare SNP with only few homozygotes and the protective association is most likely a chance finding. Furthermore, the p-value would not withstand correction for multiple testing considering the number of tests performed. On the same line, none of the two identified haplotype blocks showed any association with T2D.
###end p 49
###begin p 50
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 165 166 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Saxena1">[16]</xref>
###xml 553 559 553 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 585 586 585 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Ober1">[11]</xref>
###xml 818 824 818 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 976 982 976 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 1053 1056 1053 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke1">[5]</xref>
###xml 1058 1062 1058 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Johansen1">[17]</xref>
###xml 1415 1419 1415 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Shackelton1">[18]</xref>
###xml 1420 1424 1420 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Millis1">[20]</xref>
###xml 697 705 <span type="species:ncbi:9606">patients</span>
###xml 1229 1237 <span type="species:ncbi:9606">patients</span>
In association analyses of rs10399931 and SNPs analysed in the DGI genome wide association scan study, rs10399931 is in LD with rs4950929 (r2 = 0.74) and rs946263 (r2 = 0.78). Other correlations had r2-values<0.05. In the DGI genome wide association scan study, no significant associations of rs4950929 with any of the type 2 diabetic phenotypic traits were found, but the rs946263 G-allele was nominally found to be associated with T2D (p = 0.027) [16]. rs946263, which is a synonymous SNP located -9639 base pairs from the translational start site in CHI3LI, is also in perfect LD (r2 = 1.0) with rs4950928, which accounts for approximately 10% of the variance in plasma YKL-40 levels in asthma patients [11]. Beside the LD of rs10399931 and rs4950928 with rs946263, none of the examined SNPs or haplotype blocks of CHI3LI seem to be of any significance for the T2D diagnosis or any of the T2D related quantitative traits. Since the encoded inflammatory protein, YKL-40, of CHI3LI seems to be both a marker of inflammation and endothelial dysfunction [5], [17] it is possible that it is the endothelial dysfunction and the later micro- and macrovascular complications of T2D that accounts for the elevated YKL-40 levels in T2D patients. In endothelial dysfunction, elevated YKL-40 levels seem to play a role in relation to cell migration, reorganization and tissue remodelling as a response to endothelial damage [18]-[20].
###end p 50
###begin p 51
###xml 213 216 213 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke4">[8]</xref>
###xml 364 368 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Kucur1">[21]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Nojgaard1">[22]</xref>
###xml 646 649 646 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke3">[7]</xref>
###xml 204 212 <span type="species:ncbi:9606">patients</span>
###xml 436 444 <span type="species:ncbi:9606">patients</span>
The possible assocation between YKL-40 and vascular damage is supported by the finding of an independent association between elevated circulating YKL-40 levels and increasing levels of albuminuria in T1D patients [8]. Elevated plasma YKL-40 is also found to be associated with the presence and extent of coronary artery disease as assessed by coronary angiography [21] and just recently, YKL-40 levels have been found to be elevated in patients with myocardial infarction [22]. Furthermore, increasing YKL-40 levels do predict cardiovascular mortality in individuals without known DM or CHD after adjustment for known CV risk factors and markers [7].
###end p 51
###begin p 52
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Meigs1">[23]</xref>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Ingelsson1">[29]</xref>
###xml 439 442 439 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke2">[6]</xref>
###xml 701 704 701 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Rathcke2">[6]</xref>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
Substantial evidence supports the notion that endothelial dysfunction and low-grade inflammation play a major pathophysiological role in the development of insulin resistance and the progression to manifest T2D [23]-[29]. We have previously shown, that YKL-40 levels are elevated in patients with T2D where it correlates with insulin resistance as assessed by the HOMA model and with levels of triglycerides and non-esterified fatty acids [6]. Since we found no association of any of the tgSNPs and surrogate markers of insulin resistance or the diabetic lipid profile in the present study, it does not seem to be any of these tgSNPs that explain the previously found correlation with these variables [6].
###end p 52
###begin p 53
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Dupuis1">[30]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Vickers1">[33]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Dupuis1">[30]</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Meigs1">[23]</xref>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Kolb1">[25]</xref>
###xml 615 621 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3L1</italic>
Multiple genes on different chromosomes may influence inflammatory biomarker levels and may have a potential role in the development of insulin resistance through a low-grade inflammatory state [30]-[33]. In proximity of the YKL-40 encoding gene, locus 1q32.2 has been documented to influence the plasma levels of ICAM-1[30], an adhesion molecule well-documented to participate in endothelial dysfunction and the development of T2D [23], [25]. However, association studies between YKL-40 and ICAM-1, either at protein or transcript levels, have not been conducted. Neither have association studies of variations of CHI3L1 in relation to micro- or macrovascular conditions never been made.
###end p 53
###begin p 54
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005469-Saxena1">[16]</xref>
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
###xml 570 576 570 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHI3LI</italic>
In conclusion, both rs10399931 and rs4950928 are in high LD with rs946263 which is reported to associate with phenotypic traits of T2D in DGI [16]. However, neither rs1039991 nor rs4950928 nor any other tgSNPs of CHI3LI which were investigated in the present study are associated with T2D or T2D related quantitative traits including estimates of insulin resistance and dysregulated glucose homeostasis in the examined approximately 9500 Danes. Further studies are required to determine YKL-40 levels as a marker of inflammation in the prediabetic state and the role of CHI3LI in the pathogenesis of T2D.
###end p 54
###begin title 55
Supporting Information
###end title 55
###begin p 56
###xml 122 134 <span type="species:ncbi:9606">participants</span>
Case control association studies of 540 individuals with impaired fasting glucose (IFG) and 5302 glucose tolerant control participants in relation to the 11 tgSNPs of CHI3LI.
###end p 56
###begin p 57
(0.08 MB DOC)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
###xml 124 136 <span type="species:ncbi:9606">participants</span>
Case control association studies of 830 individuals with impaired glucose tolerance (IGT) and 5302 glucose tolerant control participants in relation to the 11 tgSNPs of CHI3LI
###end p 59
###begin p 60
(0.08 MB DOC)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
We wish to thank A. Forman, I.-L. Wantzin and M. Stendal for technical assistance and Michel Kristensen, Arne Nielsen and Grete Lademann for management and secretarial support.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
Growing evidence for diabetes susceptibility genes from genome scan data.
###end article-title 64
###begin article-title 65
Genetics of type 2 diabetes.
###end article-title 65
###begin article-title 66
Genome-wide association scans for Type 2 diabetes: new insights into biology and therapy.
###end article-title 66
###begin article-title 67
Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study.
###end article-title 67
###begin article-title 68
YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis.
###end article-title 68
###begin article-title 69
###xml 52 60 <span type="species:ncbi:9606">patients</span>
YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance.
###end article-title 69
###begin article-title 70
Low grade inflammation as measured by levels of YKL-40: Association with an increased overall and cardiovascular mortality rate in an elderly population.
###end article-title 70
###begin article-title 71
###xml 77 85 <span type="species:ncbi:9606">patients</span>
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with Type 1 Diabetes and increases with levels of albuminuria.
###end article-title 71
###begin article-title 72
A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker.
###end article-title 72
###begin article-title 73
A genome-wide association study of global gene expression.
###end article-title 73
###begin article-title 74
Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function.
###end article-title 74
###begin article-title 75
A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.
###end article-title 75
###begin article-title 76
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
###end article-title 76
###begin article-title 77
Efficiency and power in genetic association studies.
###end article-title 77
###begin article-title 78
PLINK: a tool set for whole-genome association and population-based linkage analyses.
###end article-title 78
###begin article-title 79
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
###end article-title 79
###begin article-title 80
Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer.
###end article-title 80
###begin article-title 81
Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling.
###end article-title 81
###begin article-title 82
###xml 98 103 <span type="species:ncbi:9606">human</span>
Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells.
###end article-title 82
###begin article-title 83
In vitro expression of a 38,000 dalton heparin-binding glycoprotein by morphologically differentiated smooth muscle cells.
###end article-title 83
###begin article-title 84
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Serum YKL-40 levels in patients with coronary artery disease.
###end article-title 84
###begin article-title 85
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Serum levels of YKL-40 increases in patients with acute myocardial infarction.
###end article-title 85
###begin article-title 86
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
###end article-title 86
###begin article-title 87
Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.
###end article-title 87
###begin article-title 88
An immune origin of type 2 diabetes?
###end article-title 88
###begin article-title 89
The metabolic syndrome.
###end article-title 89
###begin article-title 90
Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
###end article-title 90
###begin article-title 91
C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
###end article-title 91
###begin article-title 92
Inflammatory markers in relation to insulin resistance and the metabolic syndrome.
###end article-title 92
###begin article-title 93
Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q.
###end article-title 93
###begin article-title 94
Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population.
###end article-title 94
###begin article-title 95
Genetic influence on inflammation variables in the elderly.
###end article-title 95
###begin article-title 96
Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein.
###end article-title 96
###begin p 97
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 97
###begin p 98
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by grants from Novo Nordisk and the European Union (InterAct, grant LSHMCT-2006-037197; EUGENE2, grant LSHM-CT-2004-512013), the Research Foundation of Herlev Hospital; the Research Foundation of Copenhagen County; the Danish Medical Research Council and the Swedish Research Council (J.H.), Timber Merchant Vilhelm Bangs Foundation; Aase and Ejnar Danielsens Foundation and The Danish Diabetes Association. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 98

